Fatty acid inhibition reduces MYC expression in triple-negative breast cancer

被引:0
|
作者
Sritharan, N. [1 ]
Lee, J. [1 ]
Goga, A. [1 ]
机构
[1] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
522
引用
收藏
页码:S108 / S108
页数:1
相关论文
共 50 条
  • [1] Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
    Roman Camarda
    Alicia Y Zhou
    Rebecca A Kohnz
    Sanjeev Balakrishnan
    Celine Mahieu
    Brittany Anderton
    Henok Eyob
    Shingo Kajimura
    Aaron Tward
    Gregor Krings
    Daniel K Nomura
    Andrei Goga
    Nature Medicine, 2016, 22 : 427 - 432
  • [2] Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
    Camarda, Roman
    Zhou, Alicia Y.
    Kohnz, Rebecca A.
    Balakrishnan, Sanjeev
    Mahieu, Celine
    Anderton, Brittany
    Eyob, Henok
    Kajimura, Shingo
    Tward, Aaron
    Krings, Gregor
    Nomura, Daniel K.
    Goga, Andrei
    NATURE MEDICINE, 2016, 22 (04) : 427 - +
  • [3] Fatty acid synthetase expression in triple-negative breast cancer
    Park, Jin Hee
    Han, Hye Seung
    Lim, So Dug
    Kim, Wook Youn
    Park, Kyoung Sik
    Yoo, Young Bum
    Lee, Seung Eun
    Kim, Wan-Seop
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) : 73 - 80
  • [4] Inhibition of fatty-acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
    Camarda, Roman
    Zhou, Alicia Y.
    Kohnz, Rebecca A.
    Balakrishnan, Sanjeev
    Mahieu, Celine
    Anderton, Brittany
    Eyob, Henok
    Kajimura, Shingo
    Tward, Aaron
    Krings, Gregor
    Nomura, Daniel K.
    Goga, Andrei
    CANCER RESEARCH, 2016, 76
  • [5] Fatty Acid Synthase (FASN) expression in Triple-Negative Breast Cancer
    Vinas, G.
    Oliveras, G.
    Perez-Bueno, F.
    Giro, A.
    Blancafort, A.
    Puig-Vives, M.
    Marcos-Gragera, R.
    Dorca, J.
    Brunet, J.
    Puig, T.
    CANCER RESEARCH, 2012, 72
  • [6] Inhibition of fatty-acid oxidation as a therapy for triple-negative breast cancer
    Goga, A.
    Camarda, R.
    Zhou, A. Y.
    Kohnz, R. A.
    Balakrishnan, S.
    Anderton, B.
    Mahieu, C.
    Eyob, H.
    Krings, G.
    Nomura, D. K.
    CANCER RESEARCH, 2016, 76
  • [7] Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Lum, David H.
    Blancafort, Adriana
    Vinas, Gemma
    Oliveras, Gloria
    Perez-Bueno, Ferran
    Sarrats, Ariadna
    Welm, Alana L.
    Puig, Teresa
    CLINICAL CANCER RESEARCH, 2016, 22 (18) : 4687 - 4697
  • [8] Fatty acid synthase inhibition as a potential therapeutic target in triple-negative breast cancer
    Giro, A.
    Blancafort, A.
    Oliveras, G.
    Perez-Bueno, F.
    Dorca, J.
    Vinas, G.
    Puig, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S180 - S180
  • [9] Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer
    Yoshikawa, Katsuhiro
    Ishida, Mitsuaki
    Yanai, Hirotsugu
    Tsuta, Koji
    Sekimoto, Mitsugu
    Sugie, Tomoharu
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [10] Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
    Wang, Shengting
    Wang, Yufang
    Wang, Yue
    Li, Qian
    Zeng, Kaixuan
    Li, Xiaoming
    Feng, Xinghua
    DISCOVER ONCOLOGY, 2023, 14 (01)